FDA Says Stop-Smoking Drug May Pose Psychiatric Risks

The Food and Drug Administration issued a public health advisory about suicidal thinking and other psychiatric conditions in patients taking the smoking cessation drug Chantix, warning that it “may cause worsening of current psychiatric illness even if it is currently under control. It may also cause an old psychiatric illness to reoccur.” Learn More:  Washington [...]